About the Authors

David J. Lloyd

dlloyd@amgen.com

Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

Joan Helmering

Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

Stephen A. Kaufman

Affiliation Department of Pathology, Amgen Inc., Thousand Oaks, California, United States of America

James Turk

Affiliation Department of Pathology, Amgen Inc., Thousand Oaks, California, United States of America

Matt Silva

Affiliation Department of Research Imaging, Amgen Inc., Thousand Oaks, California, United States of America

Sergio Vasquez

Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

David Weinstein

Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

Brad Johnston

Affiliation Numira Biosciences, Salt Lake City, Utah, United States of America

Clarence Hale

Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

Murielle M. Véniant

Affiliation Department of Metabolic Disorders, Amgen Inc., Thousand Oaks, California, United States of America

Competing Interests

The authors have read the journal's policy and have the following conflicts: David Lloyd, Joan Helmering, Stephen Kaufman, James Turk, Clarence Hale, and Murielle M. Véniant are employees at Amgen Inc. David Weinstein and Brad Johnston are employees of Numira Biosciences. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: DJL MMV CH. Performed the experiments: JH SAK SV BJ. Analyzed the data: DJL JT BJ. Contributed reagents/materials/analysis tools: SV DW BJ. Wrote the paper: DJL MS MMV.